Patents by Inventor Kevin G. Connors

Kevin G. Connors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11197981
    Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: December 14, 2021
    Assignee: Solace Therapeutics, Inc.
    Inventors: Kevin G. Connors, Albert Chun-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney, William H. Gruber
  • Publication number: 20210128197
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: September 18, 2020
    Publication date: May 6, 2021
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20200324091
    Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 15, 2020
    Inventors: Kevin G. Connors, Albert Chun-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney
  • Patent number: 10799268
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: October 13, 2020
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
  • Publication number: 20200253636
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: January 13, 2020
    Publication date: August 13, 2020
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20200254226
    Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.
    Type: Application
    Filed: February 6, 2020
    Publication date: August 13, 2020
    Inventors: Kevin G. Connors, Albert Chum-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney, William H. Gruber
  • Publication number: 20200163543
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: July 3, 2019
    Publication date: May 28, 2020
    Inventors: Ernest George Schutt, Kevin G. Connors, John Gillespie, JR., Peter Dayton
  • Publication number: 20200146799
    Abstract: An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.
    Type: Application
    Filed: June 17, 2019
    Publication date: May 14, 2020
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Publication number: 20200138556
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: June 17, 2019
    Publication date: May 7, 2020
    Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William H. Gruber, Sheila Caira
  • Publication number: 20200121342
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device can be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device can be inserted through the passageway created by the access device and can be used to deliver the pressure-attenuating device to the anatomical structure. The removal device can be inserted through the passageway created by the access device and can be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: August 30, 2019
    Publication date: April 23, 2020
    Inventors: Roy H. Sullivan, III, William H. Gruber, Albert Chum-Chi Chin, Nicole M. Shugrue, Kevin G. Connors, Matthew J. Witney
  • Patent number: 10543071
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: January 28, 2020
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William Gruber, John Gillespie, Jr., Sheila Caira
  • Patent number: 10531894
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: January 14, 2020
    Assignee: Solace Therapeutics, Inc.
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
  • Patent number: 10383510
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: August 20, 2019
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
  • Patent number: 10327880
    Abstract: An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: June 25, 2019
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Publication number: 20180228512
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 16, 2018
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20180193057
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 12, 2018
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20170354491
    Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.
    Type: Application
    Filed: February 24, 2017
    Publication date: December 14, 2017
    Inventors: Kevin G. Connors, Hung Cao
  • Patent number: 9801658
    Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: October 31, 2017
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, Ryan J. Cahill
  • Publication number: 20170127929
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: October 14, 2016
    Publication date: May 11, 2017
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Peter Dayton
  • Patent number: 9615911
    Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: April 11, 2017
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, Hung Cao